Human medicines European public assessment report (EPAR): Adcetris, brentuximab vedotin, Date of authorisation: 25/10/2012, Revision: 37, Status: Authorised
Human medicines European public assessment report (EPAR): Nidlegy, bifikafusp alfa,onfekafusp alfa, Status: Application withdrawn
Paediatric clinical trials
Submitting results of paediatric studies
Human medicines European public assessment report (EPAR): Farydak, panobinostat, Date of authorisation: 28/08/2015, Revision: 14, Status: Authorised
Information on the Member States requirement for the nomination of a pharmacovigilance (PhV) contact person at national level
In-use stability testing of veterinary medicinal products - Scientific guideline
Guideline on in-use stability testing of veterinary medicinal products
Human medicines European public assessment report (EPAR): Evrysdi, risdiplam, Date of authorisation: 26/03/2021, Revision: 12, Status: Authorised
Human medicines European public assessment report (EPAR): Retacrit, epoetin zeta, Date of authorisation: 18/12/2007, Revision: 32, Status: Authorised